Benzodiazepines and risk of dementia: True association or reverse causation?

Epidemiology and Psychiatric Sciences

Volumn 22, Issue 4, 2013, Pages 307-308

  Barbui, C ^a   Gastaldon, C ^a   Cipriani, A ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Benzodiazepines; dementia; elderly; epidemiology

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE;

ARTICLE; CLINICAL PRACTICE; COGNITION; DEMENTIA; DRUG EXPOSURE; DRUG SAFETY; FOLLOW UP; HUMAN; RISK FACTOR; AGED; ANXIETY; DSM-III-R; NEUROLOGIST; OUTCOME ASSESSMENT; PSYCHOLOGIST; SLEEP DISORDER;

BENZODIAZEPINES; DEMENTIA; HUMANS; RISK FACTORS;

EID: 84896940245     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796013000358     Document Type: Article

References (4)

1. Barbui C, Cipriani A (2011). What are evidence-based treatment recommendations? Epidemiology and Psychiatric Sciences 20, 29-31.
2. Billioti de Gage S, Begaud B, Bazin F, Verdoux H, Dartigues JF, Peres K, Kurth T, Pariente A (2012). Benzodiazepine use and risk of dementia: prospective population based study. British Medical Journal 345, e6231.
3. Bocti C, Roy-Desruisseaux J, Roberge P (2012). Research paper most likely shows that benzodiazepines are used to treat early symptoms of dementia. British Medical Journal 345, e7986.
4. Coyle-Gilchrist IT, Peck LF, Rowe JB (2012). Research paper does not show causal link between benzodiazepine use and diagnosis of dementia. British Medical Journal 345, e7984.